Plenary Sessions

NO PARTIAL CREDIT

* * * THERE IS NO PARTIAL CREDIT * * * 
You MUST attend sessions in their entirety.
Certificates will be emailed approx. 4-6 weeks after the School.

Plenary A. Opening Plenary — Professional Development Responsibility and Ethics

Presenter: Dale Willetts

Description: Coming Soon.

Plenary B. A State Level Discussion on the Landscape of Substance Use in North Carolina

Presenter: Kelly Crosbie, MSW, LCSW

Description: Coming Soon.

Plenary C. Protecting Ourselves: Equipping Clinicians with Strategies for Managing Trauma Exposure

Presenter: Noga Zerubavel, PhD, LP, HSP

Description: Working with individuals who have experienced trauma can impact providers in a variety of ways. Experiencing secondary traumatic stress (STS) is one of the occupational challenges of working closely with individuals who have experienced victimization and violence. This presentation focuses on recognizing signs and symptoms of STS and implementing evidence-based strategies that help prevent and reduce STS while enhancing resilience.
Objectives:
Identify indicators of secondary traumatic stress reactions
Describe three strategies to increase provider resiliency and mitigate negative effects of secondary traumatic stress.

Plenary D. It’s Mind-boggling: Exploring the Brain’s Reward System and Addictive Behaviors

Presenter: Stephanie Jackson Grier, MS, LCAS

Description: This presentation will summarize the major psychopharmacological framework underlying SUD and the factors that involve in the transformation of some people from recreational use or misuse of alcohol or drugs to SUD. It briefly discusses how psychoactive substances produce changes in brain functioning that facilitate the development of addictive behaviors, including gambling, food addiction, sex addiction, cyber addiction, workaholism, codependent behaviors, etc. as it contributes to craving which eventually leads to relapse. I will discuss the reward pathway of the brain that deals with similarities and differences among various classes of addictive behaviors and their effects on the brain that contributes to constant “wanting” and unfulfillment. Exploration and education on identifying the “reward” our minds create to keep us in these addictive cycles.

Plenary E. A Snapshot of Prevention, Treatment, and Recovery of Cannabis in the Changing Legalization Landscape
Presenter: Merrill Norton Pharm D., D.Ph.,CMAC, CCS

Description: Cannabis policy in the United States is evolving rapidly, reshaping public attitudes, prevention efforts, treatment strategies, and recovery pathways. As legalization expands and cannabis products become increasingly potent and commercially marketed, healthcare and prevention professionals face a more complex environment than ever before. Today’s cannabis is markedly different from that of prior decades, with higher tetrahydrocannabinol (THC) concentrations, novel formulations, concentrated products, and increased availability. Simultaneously, misconceptions regarding safety, medical use, dependence potential, and mental health effects continue to influence public behavior. Recent national data indicate cannabis use continues to rise among adults, while perceptions of harm have declined substantially among adolescents and young adults.

This plenary provides a clinically grounded, evidence-informed overview of cannabis prevention, treatment, and recovery in the modern legalization era. Participants will examine current epidemiology, legalization trends, neurobiology, high-potency THC concerns, cannabis use disorder (CUD), psychiatric and medical implications, youth prevention strategies, screening and treatment interventions, and recovery approaches. Emphasis will be placed on practical, real-world implications for prevention, healthcare, and behavioral health systems navigating the changing cannabis landscape. Recent evidence regarding cannabis potency, adolescent vulnerability, psychosis risk, and public health policy will be integrated throughout.

Learning Objectives

At the completion of this plenary, participants will be able to:

  • Describe current trends in cannabis legalization and how changing policies influence prevention, treatment, and recovery systems.
  • Differentiate between traditional cannabis products and emerging high-potency THC products, concentrates, synthetics, vapes, edibles, and hemp-derived cannabinoids.
  • Explain the neurobiology and pharmacology of cannabis, including cannabinoid receptor function, reward circuitry, tolerance, dependence, and withdrawal.
  • Identify risk factors, diagnostic criteria, and clinical manifestations of Cannabis Use Disorder (CUD).
  • Discuss the impact of cannabis legalization on youth prevention, public perception, access, and commercialization.
  • Recognize psychiatric, cognitive, developmental, and medical concerns associated with cannabis use, particularly among adolescents, pregnant individuals, and vulnerable populations.
  • Apply evidence-based screening, brief intervention, motivational enhancement, and treatment approaches for problematic cannabis use.
  • Evaluate emerging recovery models and strategies for individuals seeking cannabis abstinence, moderation, or sustained recovery.
  • Integrate prevention and recovery messaging that balances public health, harm reduction, and clinical realities in legalized environments.